Myeloma in the Octogenarians: Disease Characteristics and Clinical Outcomes in the Era of Modern Anti-Myeloma Therapy

被引：0
|
作者：
Dimopoulos, Meletios A. [1 ]
Terpos, Evangelos [1 ]
Gavriatopoulou, Maria [1 ]
Kalapanida, Despoina [1 ]
Eleutherakis-Papaiakovou, Evangelos [1 ]
Roussou, Maria [1 ]
Mparmparoussi, Despoina [2 ]
Zomas, Athanasios [3 ]
Gika, Dimitra [1 ]
Kartasis, Zafiris [4 ]
Matsouka, Charis [2 ]
Kostis, Evangelos [1 ]
Kontogiannis, Sofoklis [1 ]
Konstantopoulos, Kostas [1 ]
Kastritis, Efstathios [1 ]
机构：
[1] Univ Athens, Sch Med, Athens 11528, Greece
[2] Alexandra Gen Hosp, Athens, Greece
[3] St Anargiri Canc Hosp, Athens, Greece
[4] Gen Hosp Chalkida, Chalkida, Greece
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Optimizing the Outcome of Anti-Myeloma Treatment with Daratumumab
    Plesner, Torben
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (05) : 1 - 10
  • [22] Lenalidomide enhances anti-myeloma cellular immunity
    Katarina Luptakova
    Jacalyn Rosenblatt
    Brett Glotzbecker
    Heidi Mills
    Dina Stroopinsky
    Turner Kufe
    Baldev Vasir
    Jon Arnason
    Dimitri Tzachanis
    Jeffrey I. Zwicker
    Robin M. Joyce
    James D. Levine
    Kenneth C. Anderson
    Donald Kufe
    David Avigan
    Cancer Immunology, Immunotherapy, 2013, 62 : 39 - 49
  • [23] Anti-myeloma activity of natural killer lymphocytes
    Frohn, C
    Höppner, M
    Schlenke, P
    Kirchner, H
    Koritke, P
    Luhm, J
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 119 (03) : 660 - 664
  • [24] Anti-Myeloma Effects of Panobinostat in Combination with Duvelisib
    Chen, Haiming
    Li, Mingjie
    Goldwater, Marissa
    Behare, Stacy
    Cao, Jasmin
    Wallingford, Cara
    Hekmati, Ava
    Levin, Rocky
    Souther, Eric
    Xu, Ning
    Berenson, James R.
    BLOOD, 2021, 138
  • [25] Avicins: A novel class of anti-myeloma agents
    Negri, J.
    Mitsiades, N.
    McMullan, C. J.
    Hayden, P.
    McMillin, D.
    Klippel, S.
    Tesmenitsky, Y.
    Haridas, V.
    Munshi, N.
    Richardson, P.
    Gutterman, J.
    Anderson, K. C.
    Mitsiades, C. S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 144 - 144
  • [26] Modulation of cereblon levels by anti-myeloma agents
    Diaz-Rodriguez, Elena
    Pandiella, Atanasio
    LEUKEMIA & LYMPHOMA, 2016, 57 (01) : 167 - 176
  • [27] Rupture of an extended mycotic aneurysm of the descending thoracic aorta in a multiple myeloma patient undergoing anti-myeloma therapy
    Marumoto, Akira
    Iwata, Keiji
    GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2016, 64 (03) : 163 - 166
  • [28] Rupture of an extended mycotic aneurysm of the descending thoracic aorta in a multiple myeloma patient undergoing anti-myeloma therapy
    Akira Marumoto
    Keiji Iwata
    General Thoracic and Cardiovascular Surgery, 2016, 64 : 163 - 166
  • [29] Small molecule MIRA-1 induces in vitro and in vivo anti-myeloma activity and synergizes with current anti-myeloma agents
    Saha, M. N.
    Chen, Y.
    Chen, M-H
    Chen, G.
    Chang, H.
    BRITISH JOURNAL OF CANCER, 2014, 110 (09) : 2224 - 2231
  • [30] Anti-myeloma efficacy of bisphosphonates in vivo.
    Yaccoby, S
    Johnson, CL
    Barlogie, B
    Epstein, J
    BLOOD, 1999, 94 (10) : 316A - 317A
12345